Stablepharma Ltd in collaboration with their leading global CDMO partner have achieved a significant milestone in the GMP manufacture of their lead candidate, fridge-free Tetanus Diphtheria vaccine (SPVX02), based on StablevaX™ technology. Stablepharma have reported the successful manufacture and analytical testing of over 10,000 vials (doses) of SPVX02 under GMP conditions, in Monza, Italy and […]
Read More